Archynetys
  • Home
  • Economy
  • Entertainment
  • Health
  • News
  • Sports
  • Technology and Science
  • World
Tag:

drug development

  • Health

    Sanofi Gaucher Disease Drug Shows Neurological Benefit

    by Archynetys Health Desk February 2, 2026
    by Archynetys Health Desk February 2, 2026

    Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    AI Biotech Startup Seeks $150M Funding – Ex-Google CEO

    by Archynetys Health Desk January 28, 2026
    by Archynetys Health Desk January 28, 2026

    Hologen, a secretive AI startup co-founded by former Google CEO Eric Schmidt, is seeking to raise …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    HKEY-AIRx™: New Platform for Asthma & Allergy Drug Discovery

    by Archynetys Health Desk January 28, 2026
    by Archynetys Health Desk January 28, 2026

    HKeyBio, a preclinical CRO specializing in drug development for autoimmune and allergic diseases, has launched HKEY-AIRx™ …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Roche Obesity Drug: Phase 3 Trials Confirmed

    by Archynetys Health Desk January 27, 2026
    by Archynetys Health Desk January 27, 2026

    Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Moderna, GSK, Merck & FDA Updates – Readout Newsletter

    by Archynetys Health Desk January 20, 2026
    by Archynetys Health Desk January 20, 2026

    Want to stay on top of the science and politics driving biotech today? Sign up to …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    LXR Inverse Agonist for Dyslipidemia: Preclinical & Phase 1 Data

    by Archynetys Health Desk January 16, 2026
    by Archynetys Health Desk January 16, 2026

    In vitro experiments Table of Contents In vitro experiments Biochemical binding assay LXR GAL4 reporter transient …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Linavonkibart & Pembrolizumab: Phase 1 Trial in Advanced Solid Tumors

    by Archynetys Health Desk January 14, 2026
    by Archynetys Health Desk January 14, 2026

    Competing interests T.A.Y. reports consulting fees from 858 Therapeutics, AbbVie, Acrivon, Adagene, Aeneid Therapeutics, Almac, Alterome …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Illumina, UniQure & Gene Therapy News – Readout Update

    by Archynetys Health Desk January 10, 2026
    by Archynetys Health Desk January 10, 2026

    Want to stay on top of the science and politics driving biotech today? Sign up to …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    2025 Predictions: Top Health, Science & Medicine Stories

    by Archynetys Health Desk December 27, 2025
    by Archynetys Health Desk December 27, 2025

    What a year! Yes, it was our 10th anniversarybut it also brought an unprecedented blizzard of …

    Read more
    0 FacebookTwitterPinterestEmail
  • Health

    Healthcare 2025: Top Stories & Trends | STAT

    by Archynetys Health Desk December 22, 2025
    by Archynetys Health Desk December 22, 2025

    Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how …

    Read more
    0 FacebookTwitterPinterestEmail
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8

Recent Posts

  • su familia pide ayuda y Jaime sí se presentará en Medellín

    May 7, 2026
  • Ryan Cohen’s mysterious bank letter backing his eBay bid reveals a big issue

    May 7, 2026
  • Anti-DDoS Firm Heaped Attacks on Brazilian ISPs – Krebs on Security

    May 7, 2026
  • Raja Jackson Reaches Plea Deal After Alleged In-Ring Assault

    May 7, 2026
  • Amber Rose ‘Partially’ to Blame for Kanye, Taylor Swift Drama

    May 7, 2026
  • Dentist Bacau
Archynetys
  • Home
  • Economy
  • Entertainment
  • Health
  • News
  • Sports
  • Technology and Science
  • World

Loading Comments...